KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Other Non Operating Income: 2010-2024

Historic Other Non Operating Income for Novavax (NVAX) over the last 14 years, with Dec 2024 value amounting to $40.4 million.

  • Novavax's Other Non Operating Income fell 280.34% to -$28.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year decrease of 83.34%. This contributed to the annual value of $40.4 million for FY2024, which is 6.72% up from last year.
  • According to the latest figures from FY2024, Novavax's Other Non Operating Income is $40.4 million, which was up 6.72% from $37.9 million recorded in FY2023.
  • Novavax's 5-year Other Non Operating Income high stood at $40.4 million for FY2024, and its period low was -$6.8 million during FY2021.
  • Moreover, its 3-year median value for Other Non Operating Income was $37.9 million (2023), whereas its average is $29.8 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first surged by 104,753.85% in 2020, then tumbled by 150.22% in 2021.
  • Over the past 5 years, Novavax's Other Non Operating Income (Yearly) stood at $13.6 million in 2020, then tumbled by 150.22% to -$6.8 million in 2021, then surged by 260.53% to $11.0 million in 2022, then soared by 245.48% to $37.9 million in 2023, then climbed by 6.72% to $40.4 million in 2024.